Table 1. HIV-positive final results tested at Zuckerberg San Francisco General Hospital (ZSFG), January -November 2015.
Total (January – Nov, 2015) | RT-IF1 (Jan – Aug, 2015) | AR-MS-VL2 (Sep – Nov, 2015) | |||||
---|---|---|---|---|---|---|---|
All Testers (N) | Previous HIV+ Testers (N) | HIV- /Unknown Testers (N) | New HIV Infection Prevalence3 (95%CI) | Previous HIV+ Testers (N) | HIV- /Unknown Testers (N) | New HIV Infection Prevalence3 (95%CI) | |
Total tests done | 21,985 | 197 | 16,260 | 77 | 5,430 | ||
HIV+ Cases Identified | 321 | 197 | 36 | 0.22% (0.16-0.30) | 77 | 11 | 0.20% (0.11-0.36) |
Outpatient | 15 | 4 | 3 | 0.11% (0.04-0.32) | 5 | 3 | 0.30% (0.10-0.88) |
OB | 6 | 3 | 3 | 0.16% (0.05-0.47) | 0 | 0 | 0% (0-0) |
Jail | 12 | 4 | 5 | 0.28% (0.12-0.66) | 1 | 2 | 0.30% (0.08-1.08) |
Inpatient | 49 | 36 | 7 | 0.51% (0.25-1.05) | 6 | 0 | 0% (0-0) |
ED | 34 | 25 | 6 | 0.45% (0.21-0.98) | 2 | 1 | 0.23% (0.04-1.31) |
Drop In | 69 | 39 | 12 | 0.17% (0.10-0.30) | 13 | 5 | 0.23% (0.10-0.54) |
HIV clinic | 163 | 86 | 0 | 0% (0-0) | 77 | 0 | 0% (0-0) |
Uni-Gold HIV Rapid Test (RT) for screening followed by immunofluorescence (IF) confirmation
ARCHITECT® HIV Ag/AB Combo (AR) for screening, followed by Multispot HIV-1/HIV-2 Rapid Test (MS) confirmation, and Abbott RealTime HIV-1 assay (VL) as needed for resolution of discrepant results
Prevalence is measured among those with HIV-negative or unknown status at the time of testing